Skip to content
OpenCapital
Get started

Artelo Biosciences ARTL Q3 2025 earnings

Reported November 12, 2025 · Before market open

EPS-$3.97Miss by $3.15
EPS estimate-$0.82

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.72

Versus estimates

Diluted EPS

Q1 2026-$4.00Miss by $3.22Q4 2025-$6.66Miss by $1.95
Q3 2025-$3.97Miss by $3.15
Q2 2025-$5.61Miss by $1.42Q1 2025-$4.32Miss by $3.52Q4 2024-$7.02Miss by $4.40

Ask the moment Artelo Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Artelo Biosciences report Q3 2025 earnings?
Artelo Biosciences (ARTL) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Artelo Biosciences's Q3 2025 revenue and EPS?
Artelo Biosciences reported eps of $-3.97 for Q3 2025.
Did Artelo Biosciences beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.82 by $3.15.
How did Artelo Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 89.0% from $-2.10.
Where can I find Artelo Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001640334-25-002118) and the 10-Q periodic report (0001640334-25-002022) directly on SEC EDGAR. The filing index links above go to sec.gov.